Clinical trial

Glycemic Control and Quality of Life Evolution for Patients With T1D Using the myLoop Powered by CamAPS FX System in Combination With FreeStyle Libre 3 / 3 Plus Sensors in France

NCT07835685

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention No Intervention: Observational Cohort Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Glycemic Control and Quality of Life Evolution for Patients With T1D Using the myLoop Powered by CamAPS FX System in Combination With FreeStyle Libre 3 / 3 Plus Sensors in France

Design: OBSERVATIONAL · Status: NOT YET RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2026-10-01

PhaseN/A

Conditions

Diabetes Type 1unresolved

Interventions

No Intervention: Observational CohortOTHER

Sponsors & collaborators

mylife Diabetes Care AGlead sponsor

Abbott Diabetes Care, Inc - providing financial support for the studycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07835685 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.